Cargando…

MON-LB010 Cyclic Progesterone Therapy for Androgenic Polycystic Ovary Syndrome (PCOS) - A Systematic Review of the Literature

Women living with androgenic PCOS (WLWP) experience unpredictable oligomenorrhea(1) and are at increased risk for endometrial cancer(2). Oral micronized progesterone (OMP) given cyclically (14 days/cycle or 4 weeks, Cyclic OMP), in luteal phase doses(3) (300 mg at bedtime) as a “luteal phase replace...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shirin, Sonia, Goshtasebi, Azita, Kalidasan, Dharani, Prior, Jerilynn C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209032/ http://dx.doi.org/10.1210/jendso/bvaa046.2339

Ejemplares similares

MON-LB9 Cyclic Progesterone Therapy in Androgenic Polycystic Ovary Syndrome (PCOS) - Person-Related 6-Month Experience Changes
por: Shirin, Sonia, et al.
Publicado: (2020)

Cyclic Progesterone Therapy in Androgenic Polycystic Ovary Syndrome (PCOS)—A 6-Month Pilot Study of a Single Woman’s Experience Changes
por: Shirin, Sonia, et al.
Publicado: (2021)

MON-LB042 Health-Related Quality of Life in Women with Polycystic Ovary Syndrome/Anovulatory Androgen Excess versus Local Population-Based Control Women (from the British Columbia Canadian Multicentre Osteoporosis Study [BC CaMos])
por: Liang, Bernice, et al.
Publicado: (2019)

OR15-6 Epidemic of Subclinical Ovulatory Disturbances During SARS-COV2 Pandemic—an Experiment of Nature
por: Barr, Susan, et al.
Publicado: (2022)

SUN-537 Progesterone Therapy and Serum Sclerostin Levels in Healthy Menopausal Women: A 3-month Randomized, Placebo Controlled Clinical Trial
por: Yang, Yuebo, et al.
Publicado: (2019)

Letter to the Editor From Nelson et al: “Understanding the Link Between Obesity and Severe COVID-19 Outcomes: Causal Mediation by Systemic Inflammatory Response”
por: Nelson, Kaitlin, et al.
Publicado: (2022)

Prospective analyses of sex/gender-related publication decisions in general medical journals: editorial rejection of population-based women’s reproductive physiology
por: Kalidasan, Dharani, et al.
Publicado: (2022)

MON-LB038 Reduced Exercise Endurance And Skeletal Muscle Alterations In A Prenatally Androgenized Rat Model For Polycystic Ovary Syndrome
por: DeChick, Auryana, et al.
Publicado: (2019)

MON-231 Dietary Interventions Can Ameliorate Polycystic Ovary Syndrome (PCOS) Traits in a PCOS Mouse Model
por: Rodriguez Paris, Valentina, et al.
Publicado: (2019)

MON-213 Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Factors in Reproductive-Age Women with Polycystic Ovary Syndrome (PCOS) Using the 2014 Androgen Excess and PCOS Society Criteria for the Polycystic Ovarian Morphology
por: Kazemi, Maryam, et al.
Publicado: (2019)

MON-LB043 Bariatric Surgery and Weight Loss: Effect on Glucose/Insulin Dynamics in Adolescent PCOS
por: Fennoy, Ilene, et al.
Publicado: (2019)

MON-234 Targeted Profiling of Plasma MicroRNAs in Women with Polycystic Ovary Syndrome (PCOS): Impact of Obesity
por: Almawi, Wassim, et al.
Publicado: (2019)

MON-230 Androgen-Induced Disruption of the Biological Clock: The Link between PCOS and NAFLD
por: Abudu, Aierken, et al.
Publicado: (2019)

MON-029 Polycystic Ovary Syndrome (PCOS) in Adolescent Girls:Toward a Simple On-Treatment Predictor of Post-Treatment Ovulation Rate
por: Ibanez, Lourdes, et al.
Publicado: (2020)

MON-035 Does Androgen Exposure Result in Germline Transmission of PCOS-Like Phenotypes and Can It Be Reversed?
por: Lu, Haojiang, et al.
Publicado: (2020)

MON-043 Sleep Disturbances in Women with and Without Polycystic Ovary Syndrome (PCOS) and Their Association with Lifestyle Factors (Diet, Physical Activity and Sitting Time)
por: Bennett, Christie, et al.
Publicado: (2020)

OR08-2 Androgen Receptor- Vs Estrogen Receptor-Mediated Actions in the Development of Distinct Clinical Polycystic Ovary Syndrome (PCOS) Phenotypes
por: Aflatounian, Ali, et al.
Publicado: (2019)

MON-033 Androgen Increases the Accumulation of Advanced Glycation End Products in Granulosa Cells by Activating ER Stress in PCOS
por: Azhary, Jerilee Mariam Khong, et al.
Publicado: (2020)

MON-010 Effects of Delta-9-Tetrahydrocannabinol (THC) on Oocyte Competence and Early Embryonic Development
por: Misner, Megan, et al.
Publicado: (2020)

MON-201 ER Stress Activated by Androgen Enhances Apoptosis of Granulosa Cells via Induction of Death Receptor 5 in PCOS
por: Azhary, Jerilee, et al.
Publicado: (2019)

MON-205 Is Muscle Mechanical Function Altered In Polycystic Ovary Syndrome?
por: Caliskan Guzelce, Ezgi, et al.
Publicado: (2019)

MON-022 Dissecting the Interplay Between Diet and PCOS Pathology on Gut Microbiota in a PCOS Mouse Model
por: Paris, Valentina Rodriguez, et al.
Publicado: (2020)

SAT353 Relevance of Ovarian Morphology Among Adolescents With Polycystic Ovary Syndrome (PCOS)
por: Christ, Jacob P, et al.
Publicado: (2023)

OR33-1 Metabolic Inflexibility in Obese versus Lean Women with Polycystic Ovary Syndrome (PCOS): Is PCOS Status or Adiposity the Critical Factor?
por: Gebara, Nour, et al.
Publicado: (2019)

A one-year observational cohort study of menstrual cramps and ovulation in healthy, normally ovulating women
por: Bann, Sewon, et al.
Publicado: (2022)

SUN-012 Role of Leptin-Receptor Expressing Cells in the Pathogenesis of Polycystic Ovary Syndrome (PCOS)
por: Cara, Alexandra, et al.
Publicado: (2020)

SAT388 Does Obesity Drive the Development of Polycystic Ovary Syndrome (PCOS)? An Epidemiologic Study
por: Amiri, Mina, et al.
Publicado: (2023)

SUN-LB6 Characterization of PCOS Among Flo App Users Around the World
por: Galic, Isabel, et al.
Publicado: (2020)

PMON245 Clinical Phenotypes of Polycystic Ovary Syndrome (PCOS) in Nigerian Women: Preliminary Results of the Nigeria PCOS Epidemiology & Phenotype (Nigeria-Pep) Study
por: Balogun, Mobolanle, et al.
Publicado: (2022)

SAT365 Prevalence of Polycystic Ovary Syndrome (PCOS) in Health System and Insurer Records vs. the Prevalence in the Population: Evidence for the Significant Underdiagnosis and Undertreatment of PCOS
por: Hatoum, Sana, et al.
Publicado: (2023)

MON-215 Comparison of Ultrasonographic and Biochemical Markers of Polycystic Ovarian Morphology Across the Phenotypic Spectrum of Polycystic Ovary Syndrome
por: Jarrett, Brittany, et al.
Publicado: (2019)

SUN-010 Efficacy of High Intensity Intermittent Training for Improving Cardio-Metabolic Health in Women with Polycystic Ovary Syndrome: A Pilot Study
por: Patten, Rhiannon Kate, et al.
Publicado: (2020)

MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome
por: Hoyos, Luis, et al.
Publicado: (2019)

MON-207 Identification of Monogenic Causes of Polycystic Ovary Syndrome by High Throughput Sequencing
por: Crespo, Raiane, et al.
Publicado: (2019)

MON-037 Vitamin D Levels in Women with Polycystic Ovary Syndrome: Influence of Obesity
por: Maidana, Patricia Nieves Amelia, et al.
Publicado: (2020)

FRI458 Rare Pathogenic Missense Variants in LMNA Identified in Women with Polycystic Ovary Syndrome (PCOS)
por: Bauer, Rosemary, et al.
Publicado: (2023)

SAT372 Obstructive Sleep Apnea (OSA) Risk Among Patients With Polycystic Ovary Syndrome (PCOS)
por: Christ, Jacob P, et al.
Publicado: (2023)

MON-LB7 Assessment of Endothelial Dysfunction by Flow Mediated Dilation in Postmenopausal Women
por: Chopra, Seema, et al.
Publicado: (2020)

SUN-LB5 GnRHR ECL-2 Epitopes Targeted by Activating Autoantibodies in Polycystic Ovary Syndrome
por: Guo, Yankai, et al.
Publicado: (2020)

MON-208 Association Study of AMH Promoter Polymorphisms and Serum AMH Levels in PCOS Patients
por: Moolhuijsen, Loes, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tp17ikj76r5vb83urbqofm522p